Clinical Trial Update: Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab + zimberelimab with cisplatin and nab-paclitaxel in locally advanced, operable head and neck squamous cell carcinoma (HNSCC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Nab-paclitaxel (paclitaxel protein-bound)
• Zimberelimab (zimberelimab)

Snippet

Sponsor: Xuekui Liu | Conditions: Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable | Phase 2 | Status: UNKNOWN